Xilio Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon, everyone. Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce Rene Russo, CEO of Xilio Therapeutics. Just a reminder, the format for today is a fireside chat. So if anyone has a question from the audience, please feel free to raise your hand, and we'll be sure to address your question.
Before we get started, I just need to read a quick disclosure for important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, thanks, Rene, for joining us.
Questions & Answers
And I thought maybe we could just start with a macro question. If we look
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |